ATR inhibitor M6620 (formerly VX-970) with cisplatin in metastatic triple-negative breast cancer: preliminary results from a phase 1 dose expansion cohort (NCT02157792).
Telli, ML Lord, S Abramson, V Arkenau, H Murias, C Becerra, C Tang, R Penney, M Pollard, J
Telli, ML
Lord, S
Abramson, V
Arkenau, H
Murias, C
Becerra, C
Tang, R
Penney, M
Pollard, J
Citations
Altmetric:
Abstract
Description
Date
2018-02-14
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
ATR inhibitor M6620 (formerly VX-970) with cisplatin in metastatic triple-negative breast cancer: preliminary results from a phase 1 dose expansion cohort (NCT02157792) 2018, 78(4 Suppl): OT2-07-07 Cancer Res